Prospective Grant of Exclusive Patent License: Development and Commercialization of Regulatory T-cell Therapies for the Treatment of Multiple Sclerosis

TitleProspective Grant of Exclusive Patent License: Development and Commercialization of Regulatory T-cell Therapies for the Treatment of Multiple Sclerosis
ToC Doc Development and Commercialization of Regulatory T-cell Therapies for the Treatment of Multiple Sclerosis
Docket Number2022-01330
Type Notice
Subject Prospective Grant of Exclusive Patent License:
Development and Commercialization of Regulatory T-cell Therapies for the Treatment of Multiple Sclerosis
Publication Date2022-01-25
Last Updated Date 2022-01-24 08:15:19 -0500
Last Public Inspection2022-01-24
Filed At2022-01-24T08:45:00.000-05:00
PDF 2022-01330_PI.pdf (95149 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesNational Institutes of Health

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021